There are 2789 resources available
410P - Preoperative hypoalbuminemia is associated with poor postoperative outcome in colorectal cancer patients: A systematic review and meta-analysis
Presenter: Jeremiah Wijaya
Session: ePoster Display
411P - Preoperative transarterial chemoembolization with drug-eluting beads (DEB-TACE) in patients who underwent colorectal liver metastases resection
Presenter: Yu Liu
Session: ePoster Display
412P - Surgery and stereotactic ablative body radiotherapy for colorectal cancer lung oligometastases: One centre experience
Presenter: Aida Piedra
Session: ePoster Display
444P - Prevalence of NTRK1/2/3 fusions in dMMR/MSI metastatic colorectal cancer
Presenter: Magali Svrcek
Session: ePoster Display
445P - Tumor load surrogates as major prognostic factors in BRAF-V600E mutated (mt) colorectal (CRC) patients treated with BRAF inhibitor+antiEGFR +/- MEK inhibitor
Presenter: Francisco Javier Ros Montana
Session: ePoster Display
446P - Bayesian monitoring of lapatinib (L) plus trastuzumab (T) treatment of HER2 positive metastatic colorectal cancer (mCRC): An observational cohort study
Presenter: Alessio Amatu
Session: ePoster Display
417P - Liquid biopsy driven anti-EGFR rechallenge in metastatic colorectal cancer
Presenter: Marco Puzzoni
Session: ePoster Display
418P - Upfront primary tumour resection (UPTR) and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Presenter: Manuel Benavides
Session: ePoster Display
419P - XELOX/XELIRI alternative regimen as first-line treatment of metastatic colorectal cancer (CCRCTO-2: TROT): A phase II study
Presenter: YU HAN
Session: ePoster Display
420P - A single-arm, multicenter, phase II study of anlotinib combined with CAPEOX as first-line treatment in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ALTER-C002)
Presenter: Kefeng Ding
Session: ePoster Display